EUVIMEDEUVIMED entdecken
Crossref

Costs of treatment of haemophilia A in Italy: comparison of the use of plasma-derived and recombinant FVIII using a discrete event simulation (DES) model

Mario Eandi, Lorenzo Pradelli, Massimiliano Povero

Farmeconomia. Health economics and therapeutic pathways · 2013

DOI: 10.7175/fe.65114251-74 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Farmeconomia. Health economics and therapeutic pathways, 2013. Verfasst von Mario Eandi und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Eandi, M., Pradelli, L., & Povero, M. (2013). Costs of treatment of haemophilia A in Italy: comparison of the use of plasma-derived and recombinant FVIII using a discrete event simulation (DES) model. Farmeconomia. Health economics and therapeutic pathways. https://doi.org/10.7175/fe.65114251-74

Vancouver

Eandi M, Pradelli L, Povero M. Costs of treatment of haemophilia A in Italy: comparison of the use of plasma-derived and recombinant FVIII using a discrete event simulation (DES) model. Farmeconomia. Health economics and therapeutic pathways. 2013. doi:10.7175/fe.65114251-74

BibTeX
@article{Eandi2013,
  author = {Eandi, Mario and Pradelli, Lorenzo and Povero, Massimiliano},
  title = {Costs of treatment of haemophilia A in Italy: comparison of the use of plasma-derived and recombinant FVIII using a discrete event simulation (DES) model},
  journal = {Farmeconomia. Health economics and therapeutic pathways},
  year = {2013},
  doi = {10.7175/fe.65114251-74}
}
Kostenlos starten →